» Authors » Shirley Wrobleski

Shirley Wrobleski

Explore the profile of Shirley Wrobleski including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 4
Citations 100
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Moore R, Hawley A, Sigler R, Farris D, Wrobleski S, Ramacciotti E, et al.
Ann Vasc Surg . 2009 May; 23(4):498-505. PMID: 19467832
Although there are extensive research data regarding arterial endothelial dysfunction, the effects of venous endothelial dysfunction are not well characterized. Matrix metalloproteinases (MMPs) have a defined role in vascular remodeling....
2.
Baxi S, Crandall D, Meier T, Wrobleski S, Hawley A, Farris D, et al.
Thromb Haemost . 2008 Apr; 99(4):749-58. PMID: 18392333
This study aimed to evaluate a small-molecule PAI-1 inhibitor (PAI-039; tiplaxtinin) in a rodent stenosis model of venous thrombosis in a two-phase experiment. Phase 1 determined the efficacy of tiplaxtinin...
3.
Myers Jr D, Farris D, Hawley A, Wrobleski S, Chapman A, Stoolman L, et al.
J Surg Res . 2002 Dec; 108(2):212-21. PMID: 12505044
Background: This study characterizes venous thrombosis in the mouse and examines the important role that the adhesion molecules P-selectin and E-selectin and the anti-inflammatory cytokine interleukin-10 (IL-10) play in the...
4.
Myers D, Wrobleski S, Londy F, Fex B, Hawley A, Schaub R, et al.
Thromb Haemost . 2002 Mar; 87(3):374-82. PMID: 11916067
Background: P-selectin antagonism decreases thrombosis and inflammation in animal models of venous thrombosis (VT) prophylaxis. This study defines results using a P-selectin receptor antagonist for VT treatment. Methods: Eight juvenile...